Posted On: 01/17/2016 6:28:05 PM
Post# of 72443
I do get the picture. And looking at adding to this yet again. The last 2 weeks have drawn down and caused me to re-position some of my bio portfolio. Still, Cellceutix is one of the best potential prospects, and not for the short term. If I get the time tomorrow or if you want to look for yourself I'll give you where my bio positions are...
CTIX SYN CRBP MSTX NAVB AVXL CBAY
I'm proportionally based according to risk and have recently added to SYN CTIX CBAY and SYN.
I'm not sharing this to promote my other positions, one can dd and see the different catalysts and the timing. I'm thinking the potential is much better for Cellceutix. I'm also thinking that we'll be seeing around Feb 8th an announcement for ASCO in June. There is a LOT of information concerning kevetrin's combo potential that whatever is released I'm guessing just scrapes the surface, there is so much more. And already moving forward.
CTIX SYN CRBP MSTX NAVB AVXL CBAY
I'm proportionally based according to risk and have recently added to SYN CTIX CBAY and SYN.
I'm not sharing this to promote my other positions, one can dd and see the different catalysts and the timing. I'm thinking the potential is much better for Cellceutix. I'm also thinking that we'll be seeing around Feb 8th an announcement for ASCO in June. There is a LOT of information concerning kevetrin's combo potential that whatever is released I'm guessing just scrapes the surface, there is so much more. And already moving forward.
(0)
(0)Scroll down for more posts ▼
